| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.008 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |